🇺🇸 FDA
Pipeline program

PD1-BCMA-CART

2021-BRL-202

Unknown mab active

Quick answer

PD1-BCMA-CART for Multiple Myeloma is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Multiple Myeloma
Phase
Unknown
Modality
mab
Status
active

Clinical trials